Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sleep Quality in High-Risk OSA Patients After Surgery
NCT04608331Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jan 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in Postoperative sleep disturbance (PSD), postoperative pain, sponsored by Peking University First Hospital. Started Jan 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Postoperative sleep disturbance (PSD)postoperative pain
Beyond the preview
Go deeper on NCT04608331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608331.